<SEC-DOCUMENT>0001213900-21-009265-index.html : 20210216
<SEC-HEADER>0001213900-21-009265.hdr.sgml : 20210216
<ACCEPTANCE-DATETIME>20210216083028
ACCESSION NUMBER:		0001213900-21-009265
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20210212
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210216
DATE AS OF CHANGE:		20210216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Silo Pharma, Inc.
		CENTRAL INDEX KEY:			0001514183
		STANDARD INDUSTRIAL CLASSIFICATION:	APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300]
		IRS NUMBER:				462137136
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54872
		FILM NUMBER:		21632822

	BUSINESS ADDRESS:	
		STREET 1:		560 SYLVAN AVE
		STREET 2:		SUITE 3160
		CITY:			ENGLEWOOD CLIFFS
		STATE:			NJ
		ZIP:			07632
		BUSINESS PHONE:		(718) 400-9031

	MAIL ADDRESS:	
		STREET 1:		560 SYLVAN AVE
		STREET 2:		SUITE 3160
		CITY:			ENGLEWOOD CLIFFS
		STATE:			NJ
		ZIP:			07632

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Uppercut Brands, Inc.
		DATE OF NAME CHANGE:	20190808

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Point Capital, Inc.
		DATE OF NAME CHANGE:	20130130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gold Swap Inc
		DATE OF NAME CHANGE:	20110301
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea135663-8k_silopharma.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea135663-8k_silopharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea135663ex10-1_silopharma.htm
<DESCRIPTION>MASTER LICENSE AGREEMENT, DATED FEBRUARY 12, 2021, BY AND BETWEEN THE COMPANY AND THE UNIVERSITY OF MARYLAND, BALTIMORE
<TEXT>
Document 2 - file: ea135663ex10-1_silopharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea135663ex10-2_silopharma.htm
<DESCRIPTION>LETTEROF INTENT, DATED FEBRUARY 12, 2021, BY AND BETWEEN THE COMPANY AND AIKIDO PHARMA, INC
<TEXT>
Document 3 - file: ea135663ex10-2_silopharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex10-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: ex10-1_001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex10-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: ex10-1_002.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex10-1_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: ex10-1_003.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex10-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 7 - file: ex10-2_001.jpg

</DOCUMENT>
</SEC-DOCUMENT>